How to Start GLP-1 Without a Video Visit

You may not need to schedule a call

For a lot of GLP-1 programs, a live video visit is optional — not required. Many providers approve through asynchronous intake: you fill out a structured written questionnaire, a licensed clinician reviews it on their own time, and a prescription follows if you're a suitable candidate. There is no camera call to schedule around nap time or a work meeting. This matters for a working mom because the appointment is usually the slowest, most disruptive part of getting started. This guide is educational only and not medical advice.

How asynchronous intake works

Async intake replaces the scheduled call with a thorough written form, plus review by a real clinician. You typically provide your height and weight, medical and medication history, allergies, relevant conditions, prior weight-loss attempts, and often photo ID and a recent blood pressure or lab values if you have them. Some programs ask you to upload basic labs or arrange them locally. The clinician reads all of it, may message you follow-up questions in the portal, and then either prescribes, requests more information, or declines. Nothing about "async" means "no doctor" — a licensed clinician still reviews your case and writes the prescription. It just moves the review off a shared calendar and onto theirs.

Why it saves a working mom real hours

The time cost of a synchronous visit is rarely the visit itself — it's the scheduling, the waiting room, the reschedule when a kid gets sick, and the block of your day you have to hold open. Async intake collapses that into fifteen minutes of typing whenever you have them, at 6 a.m. or 10 p.m. You answer once, then get on with your day while the clinician does their part. For dependable end-to-end speed, pair that with a provider that ships reliably — see the fastest GLP-1 telehealth for busy moms.

When a live visit is still required

Async is not universal, and honest providers say so. A synchronous visit — video or phone — may be required when your intake raises a safety flag: a complex medication list, a history of certain conditions, blood pressure or lab values that need discussion, a personal or family history of medullary thyroid carcinoma or MEN 2, pregnancy or breastfeeding, an eating-disorder history, or answers that simply need clarification before anyone prescribes. Treat a required call in those cases as the system working, not failing. Some states also mandate a live encounter — video or in-person — before a first prescription, regardless of your answers, so where you live can decide this for you. A good provider tells you upfront whether your state allows an async start.

The medicine is the same either way

Skipping the video call changes the logistics, not the treatment. The medications and the evidence behind them are identical to what you'd get after a scheduled visit — roughly 15% mean weight loss with semaglutide¹ and around 20% with tirzepatide² in the large obesity trials, all achieved under clinician supervision. Async simply removes a scheduling step; the clinical standard behind your prescription doesn't move.

If needles are the sticking point

For some women the hesitation isn't the visit — it's the injection. There is now a once-daily oral semaglutide option shown to be effective for weight loss in a large trial, which can make starting feel more approachable for the needle-averse³. Whether an oral or injectable path fits you is a conversation for the reviewing clinician, and it's exactly the kind of question a good async intake surfaces before you commit.

Where to start

If you want an async-friendly start with real oversight, CoreAge Rx is our shortlist pick: written intake, a licensed clinician reviewing every case, and dependable dispatch once you're approved — with a live visit offered where safety or your state requires it. Answer the questionnaire honestly, upload what they ask for, and let the clinician do the rest. That's the version of "fast" that respects both your time and the fact that this is real medicine.